To extend and improve the lives of cancer patients
Advantagene (d.b.a. Candel Therapeutics) is a Boston-area privately held biopharmaceutical company. We are committed to extending and improving the lives of cancer patients through the development of innovative cancer immunotherapies. Our proprietary Gene Mediated Cytotoxic Immunotherapy™ (GMCI), a platform technology designed to stimulate a patient’s immune system to naturally fight against his or her cancer, is at the forefront of these efforts.